BATONI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 11.561
AS - Asia 5.990
EU - Europa 4.789
SA - Sud America 829
AF - Africa 276
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.459
Nazione #
US - Stati Uniti d'America 11.251
SG - Singapore 1.977
CN - Cina 1.772
IT - Italia 1.459
SE - Svezia 820
HK - Hong Kong 729
BR - Brasile 693
DE - Germania 575
VN - Vietnam 493
BG - Bulgaria 314
GB - Regno Unito 286
TR - Turchia 253
FR - Francia 231
FI - Finlandia 227
CA - Canada 209
KR - Corea 185
RU - Federazione Russa 182
IN - India 165
UA - Ucraina 152
AT - Austria 115
IE - Irlanda 114
JP - Giappone 95
NL - Olanda 82
SN - Senegal 76
CH - Svizzera 72
CI - Costa d'Avorio 59
MX - Messico 51
AR - Argentina 48
BE - Belgio 42
BD - Bangladesh 41
IQ - Iraq 40
PL - Polonia 34
ID - Indonesia 33
ZA - Sudafrica 26
PK - Pakistan 25
SA - Arabia Saudita 22
ES - Italia 20
EC - Ecuador 19
EG - Egitto 19
UZ - Uzbekistan 19
NG - Nigeria 18
MA - Marocco 17
PH - Filippine 17
VE - Venezuela 17
CO - Colombia 15
NP - Nepal 14
CZ - Repubblica Ceca 13
KE - Kenya 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
DZ - Algeria 12
CL - Cile 11
PE - Perù 11
BB - Barbados 10
JO - Giordania 10
MY - Malesia 10
TH - Thailandia 10
TW - Taiwan 10
ET - Etiopia 9
KZ - Kazakistan 9
AU - Australia 8
IL - Israele 7
OM - Oman 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BJ - Benin 5
PA - Panama 5
PY - Paraguay 5
UY - Uruguay 5
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
GA - Gabon 4
LT - Lituania 4
MD - Moldavia 4
PT - Portogallo 4
QA - Qatar 4
AM - Armenia 3
CG - Congo 3
GR - Grecia 3
IR - Iran 3
LB - Libano 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
BH - Bahrain 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GT - Guatemala 2
KG - Kirghizistan 2
NI - Nicaragua 2
SD - Sudan 2
Totale 23.426
Città #
Woodbridge 1.311
Ashburn 1.121
Singapore 1.070
Ann Arbor 883
Hong Kong 716
Santa Clara 716
Fairfield 686
Houston 665
San Jose 646
Chandler 635
Dallas 563
Shanghai 346
Beijing 342
Sofia 310
Seattle 281
Serra 264
Wilmington 263
Hefei 261
Cambridge 246
New York 239
Milan 198
Los Angeles 181
Seoul 179
Izmir 170
Jacksonville 169
Ottawa 162
Boardman 157
Princeton 145
Lawrence 124
Ho Chi Minh City 121
Lauterbourg 118
Pisa 108
Medford 106
Florence 98
Dublin 96
Nanjing 95
Bremen 94
Vienna 91
Munich 87
Tokyo 85
Des Moines 82
Dakar 76
Hanoi 75
Helsinki 70
Frankfurt am Main 69
Council Bluffs 64
Istanbul 63
London 62
Dong Ket 61
Chicago 60
Abidjan 59
Bern 56
Buffalo 56
Dearborn 55
Nanchang 49
Redondo Beach 47
São Paulo 42
The Dalles 42
San Diego 41
Brussels 38
Columbus 38
Lancaster 35
Falls Church 34
Orem 34
Livorno 33
Pune 33
Kunming 31
Somma Lombardo 31
Fuzhou 29
Turku 29
Rome 28
Jüchen 27
Quanzhou 27
Porto Alegre 26
Boulder 25
Ogden 24
Redwood City 24
Guangzhou 23
Lucca 22
Changsha 21
Manchester 21
Nuremberg 21
Phoenix 21
Haiphong 20
Warsaw 20
Baltimore 19
Belo Horizonte 19
Da Nang 19
Marseille 19
Curitiba 18
Tashkent 18
Tianjin 18
Jakarta 17
Rio de Janeiro 17
Shenyang 17
Chennai 16
Nürnberg 16
Philadelphia 16
Denver 15
Lagos 15
Totale 16.251
Nome #
Biofilm growth on orthopedic implantable materials: static or dynamic condition what is the most appropriate methodological tools to study device-related infections? 377
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 283
Chitosan nanoparticles for the linear release of model cationic peptide 272
Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein 266
Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents 252
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 240
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 228
COMPLETE RELEASE OF ADENOSINE-DEAMINASE FROM MOUSE LYMPHOCYTES STABILIZED BY LOW-PH ACETATE 224
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 220
Detection of Biofilms in Biopsies from Chronic Rhinosinusitis Patients: In Vitro Biofilm Forming Ability and Antimicrobial Susceptibility Testing in Biofilm Mode of Growth of Isolated Bacteria 216
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 214
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 207
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 206
Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters 205
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 203
QUESTIONING THE ROLE OF ADENOSINE-DEAMINASE IN THE DEVELOPMENT OF LYMPHOCYTE-B IN CHICKEN BURSA 200
Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives 200
Modelli dinamici nello studio del biofilm sui materiali protesici 199
A comparison of various EIA plates for the analysis of poly-saccharide antigens and serological identification of Oral Streptococchi. New perspective on streptococci and streptococcal infections 198
PURINE METABOLISM AND B-LYMPHOCYTE DEVELOPMENT IN THE CHICKEN BURSA OF FABRICIUS 196
Ulvan as novel reducing and stabilizing agent from renewable algal biomass: Application to green synthesis of silver nanoparticles 193
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH 192
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 190
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 189
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 188
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 188
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 187
Antifouling Properties of Electrospun Polymeric Coatings Induced by Controlled Surface Morphology 187
Integrated three-dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering 186
Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guerin (BCG) 185
Innovative Biobased and Sustainable Polymer Packaging Solutions for Extending Bread Shelf Life: A Review 184
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 184
Monoclonal antibodies specific for a polysaccharide antigenic determinant of Streptococcus mutans (serotypes c,e,f) 181
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates 181
Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents 181
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 180
Miocardiopatie dilatative e miocarditi: eziopatogenesi virale 178
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 178
Lymphocytic purine metabolic disorders in tubercolin anergic mice 177
Antimicrobial peptides: promising molecules for the treatment of biofilm-associated infections. 177
Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide 177
EFFECT OF REMOVABLE ORTHODONTIC APPLIANCES ON ORAL COLONISATION BY MUTANS STREPTOCOCCI IN CHILDREN 176
The semi-synthetic peptide Lin-SB056-1 in combination with EDTA exerts strong antimicrobial and antibiofilm activity against pseudomonas aeruginosa in conditions mimicking cystic fibrosis sputum 175
Antivirulence properties of a low-molecular-weight quaternized chitosan derivative against pseudomonas aeruginosa 174
Surface acoustic wave-based lab-on-a-chip for the fast detection of Legionella pneumophila in water 172
In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells 172
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria 171
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 170
Human gamma-delta+ T cell responses to mycobacterial soluble extracts 168
Allestimento di un saggio di RT-PCR per la valutazione dell'espressione di proteine micobatteriche in campioni di espettorato 168
Microbiologia del cavo orale 168
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 167
First characterization in Italy of clinical isolates of mutans streptococci by using specific monoclonal antibodies. 167
Targeting pseudomonas aeruginosa in the sputum of primary ciliary dyskinesia patients with a combinatorial strategy having antibacterial and anti-virulence potential 167
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis 166
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 165
Identification of a novel Mycobacterium bovis BCG secretion protein 164
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 164
Streptococcus mutans has a polysaccharide antigenic determinant in common with Streptococcus porcinus 163
Reduced human beta defensin 3 in individuals with periodontal disease 161
Use of antimicrobial peptides against microbial biofilms: advantages and limits 161
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 160
BaAMPs: The database of biofilm-active antimicrobial peptides 160
1ST CHARACTERIZATION IN ITALY OF CLINICAL ISOLATES OF MUTANS STREPTOCOCCI BY USING SPECIFIC MONOCLONAL-ANTIBODIES 159
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 158
Suscettibilità di batteri orali alla betadefensina umana 3, 157
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro 157
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 156
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 155
Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides 155
Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung 154
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment 154
HIV-1 proviral DNA sequences in the saliva of patients with HIV infection. 154
Human beta-defensin-3: a promising antimicrobial peptide 154
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 154
Combination of two kinds of medicated microparticles based on hyaluronic acid or chitosan for a wound healing spray patch 154
Alta frequenza di isolamento di Streptococcus Mutans in bambini privi di lesioni cariose e con patologie ortodontiche. 153
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to Bactericidal Activity of Human beta-Defensin 3 in Biological Fluids 152
Anti-A and anti-B hemagglutinin depletion during Cohn purification process of 5% immunoglobulin 152
Emerging Multiscale Biofabrication Approaches for Bacteriotherapy 151
Characterization of polysaccharide antigen of Streptococcus porcinus type II by monoclonal antibody 151
Incidence of mutans streptococci in insulin-dependent diabetes mellitus patients 151
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure. 149
Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. 148
Effect of removable orthodontic appliances on oral colonisation by mutans streptococci in children 148
gamma-delta+ and CD4+alpha-beta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts 146
The secretion antigen SA5K has a role in the adaptation of Mycobacterium bovis bacillus Calmette-Guérin to intracellular stresses and hypoxia 146
Serological identification of mutans Streptococci using MAbs in comparison with biochemical and DNA-DNA hibridisation techniques 145
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells 144
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria 144
Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections 144
QSAR Model on Adenosine Derivatives as Antifungal Agents against Candida albicans: a Data Mining Approach 143
Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages 143
QSAR model on adenosine derivatives as antifungal agents against Candida albicans: a data mining approach 143
Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11 143
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option? 142
Proliferation of distinct human T-cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium 141
In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains 141
INVIVO STUDY OF THE INTERACTION OF HHV6 (HUMAN HERPESVIRUS-6) WITH HIV-1 140
Totale 17.741
Categoria #
all - tutte 63.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 73 192
2021/20221.514 43 82 27 107 245 230 42 74 77 43 102 442
2022/20232.161 271 287 167 261 176 286 21 169 346 10 121 46
2023/20241.595 171 108 223 65 165 273 59 153 77 66 77 158
2024/20255.236 69 199 65 334 543 569 453 242 571 659 620 912
2025/20265.879 480 667 744 456 643 531 971 375 425 470 117 0
Totale 23.819